Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1116 of 5804
-
Probiotic drink offers hope for coeliac sufferers with persistent gut pain
Symptom relief Recruiting nowCoeliac Disease (CD) is a lifelong autoimmune condition where eating gluten (a protein found in wheat, barley, and rye) causes damage to the small intestine. It affects around 1 in 100 people. Most individuals feel better and their gut heals after switching to a strict gluten-fre…
Phase: NA • Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Sound waves vs. tumors: new registry tracks Non-Surgical breakthrough
Disease control Recruiting nowHistotripsy is a treatment that uses focused ultrasound waves to break down tissue without surgery. The ultrasound waves meet at a specific spot and turn the tissue into liquid. This study is a prospective observational registry of participants receiving histotripsy. The goal of …
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
AI listens for warning signs of psychosis relapse
Knowledge-focused Recruiting nowThis observational, multinational study assesses the feasibility of speech and self-report data collection across six languages for Artificial Intelligence (AI)-driven relapse risk estimation in psychosis. Over 12 months, patients at risk of relapse and healthy controls will prov…
Sponsor: Philipp Homan • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Could zapping the brain help people with a rare form of Alzheimer's see better?
Symptom relief Recruiting nowThis study is being completed to learn if high-definition transcranial direct current stimulation (HD-tDCS) has an effect on visual and thinking abilities in persons with posterior cortical atrophy (PCA). Participants will be randomized to receive real or sham HD-tDCS (8 sessions…
Phase: NA • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New hope for bedsores: 2,000-Patient trial tests advanced wound matrices
Disease control Recruiting nowA multicenter prospective modified platform trial evaluating several cellular, acellular, and matrix like products and standard of care versus matched standard of care controls in the management of nonhealing pressure ulcers.
Phase: PHASE4 • Sponsor: Sequence LifeScience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Sticky patch could catch hidden heart problem after stroke
Diagnosis Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of a wearable device in detecting previously undiagnosed atrial fibrillation through non-invasive long-term monitoring using a wearable single-lead ECG patch (MEMO Patch M, MEMO Patch2) in 100 patients with Embolic …
Phase: NA • Sponsor: Asan Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:02 UTC
-
New breast cancer surgery could spare women from unnecessary lymph node removal
Disease control Recruiting nowThe present study aims to avoid axillary lymph node dissection (ALND) in patients with an Ultrasound (US) detected positive preoperative lymph node involvement (1 or 2 suspicious lymph-nodes) and a needle histology/cytology placing a marker in the most suspicious node undergoing …
Sponsor: European Institute of Oncology • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New MRI technique aims to spare saliva glands during cancer radiation
Symptom relief Recruiting nowRadiation-induced xerostomia (dry mouth) is one of the most common and severe side effects for patients receiving radiation therapy for head and neck cancer. New approaches are needed to reduce this side effect and improve patients' quality of life after treatment. This is a Pha…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
New MRI scan could reveal hidden brain tumors
Diagnosis Recruiting nowThis study will evaluate a new type of MRI sequence designed to improve the visibility of brain metastases after gadolinium contrast injection. The purpose is to determine whether this novel "gadolinium-weighted" imaging method can detect more or smaller tumors than standard MRI …
Sponsor: Region Stockholm • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
Sweat it out: exercise may supercharge lung cancer immunotherapy
Symptom relief Recruiting nowThis clinical trial studies how well exercise training works in improving immune activity and treatment tolerance and response in patients with non-small cell lung cancer (NSCLC) who are receiving immunotherapy. Immunotherapy may induce changes in the body's immune system and may…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
New mesh stent aims to seal brain aneurysms without surgery
Disease control Recruiting nowThe purpose of this study is to assess how safe choydar flow-directed mesh stent is and how well it works in the treatment of unruptured intracranial aneurysms (a condition in which a bulging blood vessel in the brain can burst and cause bleeding) in a real-world setting.
Sponsor: Johnson & Johnson Medical (Shanghai) Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Timing is everything: new trial challenges standard wait for pancreatitis procedure
Disease control Recruiting nowPancreatic necrosis complicates approximately 20-30% of severe acute pancreatitis cases. While many collections resolve without intervention, persistent symptomatic collections-particularly when infected-are associated with significant morbidity and mortality and frequently requi…
Phase: NA • Sponsor: Orlando Health, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Gene therapy injection aims to save sight in rare eye disease
Disease control Recruiting nowA Phase 1/2, open-label, non-randomized, dose-escalation study, where a minimum of 9 and a maximum of 18 eligible patients with Stargardt Disease will be enrolled sequentially in up to 3 dose cohorts of RTx-021. Enrolled patients will receive a single, unilateral intravitreal inj…
Phase: PHASE1, PHASE2 • Sponsor: Ray Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New combo therapy aims to stop suicide in PTSD veterans
Symptom relief Recruiting nowThe purpose of this research is to see if Crisis Response Planning (CRP), a brief strategy designed to help people cope effectively with emotional crises, combined with Cognitive Processing Therapy (CPT), a talk treatment for posttraumatic stress disorder (PTSD), will reduce suic…
Phase: NA • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New drug combo aims to tackle Hard-to-Treat prostate cancer
Disease control Recruiting nowANDROMEDA is a first-in-human, Phase I/II, open-label, multicenter study of AZD9750 in participants with metastatic prostate cancer. The trial evaluates safety, tolerability, pharmacokinetics/pharmacodynamics, and preliminary efficacy of AZD9750 as monotherapy and in combination …
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Spinal device offers new hope for women with chronic pelvic pain
Symptom relief Recruiting nowSacral neuromodulation (SNM) is a safe, effective, and minimally invasive FDA approved treatment for urinary and fecal incontinence, urinary frequency, urgency, and urinary retention. In this study we are assessing the effectiveness of sacral neuromodulation in women with sufferi…
Phase: NA • Sponsor: Corewell Health East • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Could a poop pill slow ALS? small trial launches
Disease control Recruiting nowThis is a 24-week study of intestinal microbiome transplant in people with ALS. All participants will be evaluated clinically in person for 4 visits. Blood and mailed/ fresh stool samples will also be collected. Blood samples will be used to determine changes in neurofilament lig…
Phase: PHASE1, PHASE2 • Sponsor: Duke University • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New study tests if adding a biologic drug helps kids with arthritis
Disease control ENROLLING_BY_INVITATIONThis open labelled randomized controlled trial will be carried out at the University of Child Health and the Children's Hospital, Lahore consisting of 6 months . In total 60 patients (30 in each group) fulfilling the inclusion criteria will be selected and enrolled in this study.…
Phase: PHASE3 • Sponsor: University of Child Health Sciences and Children's Hospital, Lahore • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Gut health boost may tame immunotherapy side effects in head and neck cancer
Disease control Recruiting nowphase II, randomized, double-blind, placebo controlled, non pharmacological clinical trial that aims to determine the effect of postbiotics Postbiotix-HLA™ on immuno-related adverse events (irAEs) in patients with recurrent/metastatic head and neck squamous cell carcinoma (RM HNS…
Phase: PHASE2 • Sponsor: Gruppo Oncologico del Nord-Ovest • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Precision radiation may spare rectal cancer patients from surgery
Disease control Recruiting nowThe goal of this prospective study is to evaluate if a higher radiation dose to the tumor can increase the organ preservation rate in non-locally advanced rectal cancer.
Phase: NA • Sponsor: Claudia Schuurhuizen • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC